GMC-306

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameGMC-306
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D1 receptor antagonistsSerotonin 2c (5-HT2c) receptor antagonistsDopamine D2 receptor antagonists +[4] 
TargetsSerotonin 2c (5-HT2c) receptorDopamine D1 receptorSerotonin 2a (5-HT2a) receptor +[4] 
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck KGaA, Darmstadt, GermanyUniversity Of Groningen, The NetherlandsUniversity of Gothenburg +[4] 
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Groningen, The NetherlandsH. Lundbeck A/SMerck KGaA, Darmstadt, Germany +[4] 
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A